Significant Drugs of Limited Commercial Value: Report
Washington, DC: Food and Drug Administration, 1979. 163 p.
Showing items related by title, author, creator and subject.
A Bill to Amend the Federal Food, Drug, and Cosmetic Act to Make the Secretary of Health, Education, and Welfare Responsible for the Testing and Evaluation of All Drugs to Determine Whether Such Drugs Meet the Requirements for Commercial Distribution, and to Provide for the Establishment of a National Drug Testing and Evaluation Center, and for Other Purposes Unknown creator (United States. Congress. Senate, 1979)